Difference between revisions of "Dual specificity phosphatase Cdc25B"

From Cysteinome
Jump to: navigation, search
(Created page with "{| align="left" | __TOC__ |} {{#invoke:InfoboxforTarget|run|CDC25B, M-phase inducer phosphatase 2|[https://www.uniprot.org/uniprot/P30305 P30305]|Homo sapiens|Cys440, Cys4...")
 
(Reference)
 
(3 intermediate revisions by the same user not shown)
Line 2: Line 2:
 
   | __TOC__
 
   | __TOC__
 
   |}
 
   |}
{{#invoke:InfoboxforTarget|run|CDC25B, M-phase inducer phosphatase 2|[https://www.uniprot.org/uniprot/P30305 P30305]|Homo sapiens|Cys440, Cys486|[http://pfam.xfam.org/family/PF06617 M-phase inducer phosphatase (MPI) phosphatase family]|[[:Category:Dual specificity phosphatase Cdc25B|Ligand list]]|Transcription factor}}
+
{{#invoke:InfoboxforTarget|run|CDC25B, M-phase inducer phosphatase 2|[https://www.uniprot.org/uniprot/P30305 P30305]|Homo sapiens|Cys440, Cys486|[http://pfam.xfam.org/family/PF06617 M-phase inducer (MPI) phosphatase family]|[[:Category:Dual specificity phosphatase Cdc25B|Ligand list]]|Phosphatase,<br/>Post-translational Modification}}
 
==Summary==
 
==Summary==
  
Line 56: Line 56:
 
# Ueda K, Usui T, Nakayama H, et al. '''4‐Isoavenaciolide covalently binds and inhibits VHR, a dual‐specificity phosphatase[J].''' FEBS letters, 2002, 525(1-3): 48-52. [https://www.ncbi.nlm.nih.gov/pubmed/?term=12163160 12163160]<br/>
 
# Ueda K, Usui T, Nakayama H, et al. '''4‐Isoavenaciolide covalently binds and inhibits VHR, a dual‐specificity phosphatase[J].''' FEBS letters, 2002, 525(1-3): 48-52. [https://www.ncbi.nlm.nih.gov/pubmed/?term=12163160 12163160]<br/>
  
[[Category:Targets|Targets]]
+
[[Category:Targets]]
[[Category:Homo sapiens|Homo sapiens]]
+
[[Category:Homo sapiens]]
[[Category:Phosphatase|Phosphatase]]
+
[[Category:Phosphatase]]
[[Category:MPI phosphatase family|MPI phosphatase family]]
+
[[Category:Post-translational Modification]]
[[Category:MAPK signaling pathway|MAPK signaling pathway]]
+
[[Category:MPI phosphatase family]]
[[Category:Cell cycle|Cell cycle]]
+
[[Category:MAPK signaling pathway]]
[[Category:Progesterone-mediated oocyte maturation|Progesterone-mediated oocyte maturation]]
+
[[Category:Cell cycle]]
[[Category:MicroRNAs in cancer|MicroRNAs in cancer]]
+
[[Category:Progesterone-mediated oocyte maturation]]
 +
[[Category:MicroRNAs in cancer]]

Latest revision as of 22:17, 19 August 2019

Basic Information
Short Name CDC25B, M-phase inducer phosphatase 2
UNP ID P30305
Organism Homo sapiens
Cys Site Cys440, Cys486
Family/Domain M-phase inducer (MPI) phosphatase family
Known Ligand Ligand list
Function Type Phosphatase,
Post-translational Modification

Summary

Protein Function

M-phase inducer phosphatase 2 is an enzyme that in humans is encoded by the CDC25B gene.
CDC25B is a member of the CDC25 family of phosphatases. CDC25B activates the cyclin dependent kinase CDC2 by removing two phosphate groups and it is required for entry into mitosis. CDC25B shuttles between the nucleus and the cytoplasm due to nuclear localization and nuclear export signals. The protein is nuclear in the M and G1 phases of the cell cycle and moves to the cytoplasm during S and G2. CDC25B has oncogenic properties, although its role in tumor formation has not been determined. Multiple transcript variants for this gene exist. (From Wikipedia)

Cys Function & Property

Cys486 is the active site of CDC25B, and Cys440 is very close to this site in space.

  • Hydrophobic property:
517-hydro.png
  • SASA:
Cys440: 0.411 A^2
Cys486: 2.207 A^2

Protein Sequence

MEVPQPEPAP GSALSPAGVC GGAQRPGHLP GLLLGSHGLL GSPVRAAASS
PVTTLTQTMH DLAGLGSETP KSQVGTLLFR SRSRLTHLSL SRRASESSLS
SESSESSDAG LCMDSPSPMD PHMAEQTFEQ AIQAASRIIR NEQFAIRRFQ
SMPVRLLGHS PVLRNITNSQ APDGRRKSEA GSGAASSSGE DKENDGFVFK
MPWKPTHPSS THALAEWASR REAFAQRPSS APDLMCLSPD RKMEVEELSP
LALGRFSLTP AEGDTEEDDG FVDILESDLK DDDAVPPGME SLISAPLVKT
LEKEEEKDLV MYSKCQRLFR SPSMPCSVIR PILKRLERPQ DRDTPVQNKR
RRSVTPPEEQ QEAEEPKARV LRSKSLCHDE IENLLDSDHR ELIGDYSKAF
LLQTVDGKHQ DLKYISPETM VALLTGKFSN IVDKFVIVDC RYPYEYEGGH
IKTAVNLPLE RDAESFLLKS PIAPCSLDKR VILIFHCEFS SERGPRMCRF
IRERDRAVND YPSLYYPEMY ILKGGYKEFF PQHPNFCEPQ DYRPMNHEAF
KDELKTFRLK TRSWAGERSR RELCSRLQDQ

Structural Information

  • Known structure with covalent ligand:
1CWS, 1CWT
  • Protein structure:
517-2.png

Related Pathway

Experimental Evidence

Crystallography, MALDI-TOF/MS, Western Blot, Endoproteinase Lys-C Digest, Tryptic Digest

Reference

  1. Reynolds R A, Yem A W, Wolfe C L, et al. Crystal structure of the catalytic subunit of Cdc25B required for G2/M phase transition of the cell cycle[J]. Journal of molecular biology, 1999, 293(3): 559-568. 10543950
  2. Tsuchiya A, Asanuma M, Hirai G, et al. CDC25A-inhibitory RE derivatives bind to pocket adjacent to the catalytic site[J]. Molecular BioSystems, 2013, 9(5): 1026-1034. 23467652
  3. Ueda K, Usui T, Nakayama H, et al. 4‐Isoavenaciolide covalently binds and inhibits VHR, a dual‐specificity phosphatase[J]. FEBS letters, 2002, 525(1-3): 48-52. 12163160